• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的抗磷脂抗体。

Antiphospholipid antibodies in inflammatory bowel diseases.

作者信息

Martinović Z, Perisić K, Pejnović N, Lukacević S, Rabrenović L, Petrović M

机构信息

Military Medical Academy, Clinic for Gastroenterology, Belgrade.

出版信息

Vojnosanit Pregl. 1998 Mar-Apr;55(2 Suppl):47-9.

PMID:9623359
Abstract

Patients with inflammatory bowel diseases are susceptible to thrombosis in the active phase of the disease. Tests and some factors of coagulability have shown the existence of hypercoagulability of the blood in the active phase of these diseases. In the last few years some authors have found increased levels of antiphospholipid antibodies in the blood of patients with severe forms of Crohn's disease and ulcerative colitis. In a prospective study anticardiolipin antibodies have been measured in the blood of 12 patients, eight with ulcerative colitis and four with Crohn's disease. Six patients with ulcerative colitis and two with Crohn's disease were in the active phase of the disease, and the others in the remission. None of the patients had any clinical signs of thrombosis. Anticardiolipin antibodies were slightly increased in only one patient with severe ulcerative colitis complicated with erythema nodosum and swelling of the ankles. In nine patients anticardiolipin antibodies were in the normal range, but in two they were not found. Results of our study do not allow any definite conclusion regarding the possible role of antiphospholipid antibodies in the development of thrombosis in inflammatory bowel diseases: the number of the patients is relatively low and in half of the cases the disease was moderately active. Further studies are therefore necessary.

摘要

炎症性肠病患者在疾病活动期易发生血栓形成。凝血检测及一些凝血相关因素表明,这些疾病活动期存在血液高凝状态。在过去几年中,一些作者发现重症克罗恩病和溃疡性结肠炎患者血液中抗磷脂抗体水平升高。在一项前瞻性研究中,检测了12例患者血液中的抗心磷脂抗体,其中8例为溃疡性结肠炎患者,4例为克罗恩病患者。6例溃疡性结肠炎患者和2例克罗恩病患者处于疾病活动期,其余患者处于缓解期。所有患者均无血栓形成的临床体征。仅1例重症溃疡性结肠炎合并结节性红斑和踝关节肿胀的患者抗心磷脂抗体略有升高。9例患者抗心磷脂抗体在正常范围内,但2例未检测到。我们的研究结果无法就抗磷脂抗体在炎症性肠病血栓形成中的可能作用得出任何明确结论:患者数量相对较少,且半数病例疾病为中度活动期。因此,有必要进行进一步研究。

相似文献

1
Antiphospholipid antibodies in inflammatory bowel diseases.炎症性肠病中的抗磷脂抗体。
Vojnosanit Pregl. 1998 Mar-Apr;55(2 Suppl):47-9.
2
Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.炎症性肠病中抗酿酒酵母甘露聚糖抗体:不同检测方法的比较及其与临床特征的相关性
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1143-52. doi: 10.1111/j.1365-2036.2004.02258.x.
3
[Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].布列塔尼地区炎症性肠病的发病率(1994 - 1995年)。ABERMAD。贝托讷消化器官疾病研究与协会
Gastroenterol Clin Biol. 1997;21(6-7):483-90.
4
Autoimmunity, inflammatory bowel disease and hyposplenism.
Q J Med. 1991 Jan;78(285):59-63.
5
[Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].1993年和1994年普伊-德多姆省炎症性肠病的发病率。EPIMICI。隐源性肠道炎症性疾病流行病学研究组
Gastroenterol Clin Biol. 1997;21(6-7):491-6.
6
Hemostatic abnormalities in inflammatory bowel disease.
Thromb Res. 1996 Apr 15;82(2):137-46. doi: 10.1016/0049-3848(96)00060-6.
7
[Prevalence and role of anticardiolipin antibodies in Crohn disease].
Gastroenterol Clin Biol. 1996;20(8-9):633-7.
8
Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.炎症性肠病中的抗中性粒细胞胞浆自身抗体
Gastroenterol Clin Biol. 1992;16(8-9):656-60.
9
Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review.炎症性肠病相关脑静脉血栓形成:8 例病例报告及文献复习。
Int J Stroke. 2011 Dec;6(6):487-92. doi: 10.1111/j.1747-4949.2011.00620.x. Epub 2011 Oct 21.
10
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.普通肝素在高活性炎症性肠病患者治疗中的应用
Am J Gastroenterol. 1999 Jun;94(6):1551-5. doi: 10.1111/j.1572-0241.1999.01143.x.

引用本文的文献

1
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.克罗恩病中抗磷脂抗体的患病率、意义及预测价值
World J Gastroenterol. 2015 Jun 14;21(22):6952-64. doi: 10.3748/wjg.v21.i22.6952.